Results 111 to 120 of about 22,180 (202)

Efficacy and Safety of Second‐Generation Antipsychotics for Irritability Associated With Autism Spectrum Disorder: A Systematic Review and Network Meta‐Analysis

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Objective To assess, by a systematic review and network meta‐analysis, the comparative efficacy and safety of second‐generation antipsychotics in managing aggressive behavior associated with autism spectrum disorder in children and adults. Methods Searches were conducted in MEDLINE, Embase, CENTRAL, PsycINFO, LILACS, CINAHL, trial registries ...
Luis Phillipe Nagem Lopes, Mariana Del Grossi Moura, Elisangela Costa Lima, Lauren Giustti Mazzei, Cristiane de Cássia Bergamaschi, Flávia Casale Abe, Jardel Corrêa de Oliveira, Luciane Cruz Lopes   +7 more
wiley   +1 more source

Adjunctive aripiprazole for amisulpride-induced hyperprolactinemia: a preliminary retrospective study showing no reversing effect. [PDF]

Ther Adv Psychopharmacol
Lan X, Zhuang H, Li P.
europepmc   +1 more source

The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
Current bladder cancer therapies can cause toxicity and bladder dysfunction. Brief intravesical‐like aripiprazole exposure reduced bladder cancer cell viability and was associated with redox stress and caspase‐3 activation, while ex vivo findings suggested preserved bladder structure and function, warranting further investigation as a potential ...
Liam A. O'Callaghan, Katie Powell, Russ Chess‐Williams, Catherine McDermott   +3 more
wiley   +1 more source

Brexpiprazole mitigates hyperprolactinaemia induced by paliperidone in a patient with a history of skin reaction to aripiprazole: case report introducing a new therapeutic approach. [PDF]

BJPsych Open
Humbert-Claude M, Barbé T, Ionescu MC, Khasian M, Khachouf OT, Blanc AL, Lemoullec-Tourtier D, Widmer N.   +7 more
europepmc   +1 more source

Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study. [PDF]

Front Neurol
Goto F, Wasano K.
europepmc   +1 more source

Effective Treatment With Olanzapine for Burning Mouth Syndrome With Denture Intolerance in an Older Patient: A Case Report

Gerodontology, Volume 43, Issue 2, Page 272-275, June 2026.
ABSTRACT Introduction Burning mouth syndrome (BMS) is occasionally accompanied by denture intolerance. Case Presentation An 80‐year‐old woman with complaints of residual and relapsed intraoral pain and denture intolerance due to BMS was improved by olanzapine without severe adverse events, and her eating ability was successfully restored.
Motoko Watanabe, Masanao Inokoshi, Chizuko Maeda, Chihiro Takao, Risa Tominaga, Yasuyuki Kimura, Takahiko Nagamine, Akira Toyofuku   +7 more
wiley   +1 more source

Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes. [PDF]

CNS Drugs
Wang E, Liu Y, Wang Y, Han X, Zhou Y, Zhang L, Tang Y.   +6 more
europepmc   +1 more source

Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia. [PDF]

Neuropsychiatr Dis Treat
Hu W, Huang B, Guo X, Yin X, Wang X, Ji Y, Zheng Y, Gao T, Shi C, Yu X, Pu C.   +10 more
europepmc   +1 more source

Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United States. [PDF]

J Manag Care Spec Pharm
Chan CM, Mayanil T, Chengappa KNR, Suh K.   +3 more
europepmc   +1 more source

Diazepam combined with aripiprazole in the treatment of a catatonic stupor patient with venous thrombosis: a case report. [PDF]

Front Psychiatry
Chen H, Lai T, Jin W, Xia H, Sun F.
europepmc   +1 more source